These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5627452)

  • 21. A side by side comparison of cytology and biomarkers for bladder cancer detection.
    Schroeder GL; Lorenzo-Gomez MF; Hautmann SH; Friedrich MG; Ekici S; Huland H; Lokeshwar V
    J Urol; 2004 Sep; 172(3):1123-6. PubMed ID: 15311054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
    Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
    Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
    Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic cytology in the clinical aspects of bladder and breast neoplasms].
    Rasà G
    G Ital Chir; 1966 Jul; 22(4):447-73. PubMed ID: 5984318
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cytodiagnosis of bladder cancer].
    Braxs A; Braxs J
    Rev Fac Cienc Med Cordoba; 1966; 24(2):147-50. PubMed ID: 5965791
    [No Abstract]   [Full Text] [Related]  

  • 27. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leiomyosarcoma of the urinary bladder: a diagnostic challenge in urine cytology.
    Hemachandran M; Nada R; Rajwanshi A
    Diagn Cytopathol; 2004 Oct; 31(4):281-2. PubMed ID: 15452910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of exfoliative cytology in the diagnosis of bladder tumors].
    Proca E; Lucan M; Popovici D
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1982; 31(1):1-7. PubMed ID: 6212969
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pathology and cytology of urinary bladder tumors (author's transl)].
    Namiki T
    Rinsho Byori; 1981 Mar; 29(3):270-7. PubMed ID: 7265520
    [No Abstract]   [Full Text] [Related]  

  • 31. [Value of cytological examination for postoperative bladder cancer].
    Kawachi Y
    Hinyokika Kiyo; 1983 Nov; 29(11):1469-74. PubMed ID: 6677099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cyto-histodiagnosis (cell block method) and smear cytodiagnosis].
    Fukushima N; Kakihana M; Tabayashi A; Ozaki I
    Rinsho Byori; 1971 Aug; 19():Suppl:91-2. PubMed ID: 5168193
    [No Abstract]   [Full Text] [Related]  

  • 33. FISHing and beyond in urinary cytology.
    Dahmoush L; Cohen MB
    Diagn Cytopathol; 2004 Oct; 31(4):201. PubMed ID: 15386797
    [No Abstract]   [Full Text] [Related]  

  • 34. Location of primary and recurrent superficial bladder tumors and benefits of selective biopsies.
    Hanus M; Matousková M
    Neoplasma; 1994; 41(2):119-22. PubMed ID: 8208315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytodiagnosis and biopsy: cytodiagnosis from the pathological viewpoint].
    Okada S
    Rinsho Byori; 1983 Dec; 31 Suppl():44-56. PubMed ID: 6677730
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary malignant lymphoma of the urinary bladder with a positive cytologic report.
    Mincione GP
    Acta Cytol; 1982; 26(1):69-72. PubMed ID: 6950628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer.
    Bonner RB; Liebert M; Hurst RE; Grossman HB; Bane BL; Hemstreet GP
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):971-8. PubMed ID: 8959319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia.
    Woodman AC; Goodison S; Drake M; Noble J; Tarin D
    Clin Cancer Res; 2000 Jun; 6(6):2381-92. PubMed ID: 10873090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of cytologic examinations for diagnosis of recurrence of epithelial neoplasms of the urinary bladder].
    Stapor K; Kuźmicka J
    Pol Przegl Chir; 1968 Apr; 40(4):402-11. PubMed ID: 5670642
    [No Abstract]   [Full Text] [Related]  

  • 40. The value of morphological methods in the early diagnosis of tumours of the urinary bladder.
    Cărnaru S; Serbănescu M
    Rom Med Rev; 1968; 12(4):11-8. PubMed ID: 5703530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.